Safety and efficacy of B7-H3 targeting CAR-T cell therapy for patients with recurrent GBM

被引:0
|
作者
Zhang, Yang
Feng, Rui
Chi, Xiaohan
Xian, Na
Chen, Xianzhen
Huang, Na
Zhang, Yu
Zhang, Kangna
Zhang, Jindong
Chen, Lieping
Ji, Nan
Huang, Gangxiong
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[2] Fuzhou Tcelltech Biol Sci & Technol Inc, Fuzhou, Peoples R China
[3] Yale Canc Ctr, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2062
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [41] Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia
    Zhao, Yifan
    Bai, Xue
    Guo, Shujing
    Zhang, Xiaomei
    Liu, Jile
    Zhao, Mohan
    Xie, Tianle
    Meng, Haotian
    Zhang, Yu
    He, Xiaoyuan
    Zhao, Mingfeng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [42] Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells
    Zhang, Yida
    He, Lile
    Sadagopan, Ananthan
    Ma, Tao
    Dotti, Gianpietro
    Wang, Yufeng
    Zheng, Hui
    Gao, Xin
    Wang, Dian
    DeLeo, Albert B.
    Fan, Song
    Sun, Ruochuan
    Yu, Ling
    Zhang, Liyuan
    Wang, Gongxian
    Ferrone, Soldano
    Wang, Xinhui
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (03) : 577 - 588
  • [43] B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
    Ma, Juan
    Ma, Pan
    Zhao, Chenghai
    Xue, Xin
    Han, Huamin
    Liu, Changzhen
    Tao, Hua
    Xiu, Weigang
    Cai, Jia
    Zhang, Man
    ONCOTARGET, 2016, 7 (20) : 29480 - 29491
  • [44] Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers
    Zhang, Xiaoshuai
    Guo, Haiyan
    Chen, Jie
    Xu, Chenxiao
    Wang, Lei
    Ke, Yong
    Gao, Yang
    Zhang, Baohong
    Zhu, Jianwei
    CANCER LETTERS, 2023, 572
  • [45] Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
    Wu, Huantong
    Xu, Zhuofan
    Qi, Maoyang
    Liu, Penghao
    Zhang, Boyan
    Wang, Zhenglin
    Chen, Ge
    Liu, Xiaohai
    Liu, Junqi
    Wei, Wei
    Duan, Wanru
    Chen, Zan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (10)
  • [46] Lymphoma immunotherapy: Efficacy, safety, and accessibility to CAR-T therapy for lymphomas
    Borchmann, Peter
    HEMASPHERE, 2018, 2 : 93 - 95
  • [47] Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy
    Dolnikov, Alla
    Klamer, Guy
    Chitranjan, Arjanna
    Xu, Ning
    Shen, Sylvie
    Micklethwaite, Kenneth P.
    Lock, Richard B.
    O'Brien, Tracey
    BLOOD, 2014, 124 (21)
  • [48] A CAR-T CELL THERAPY TARGETING GLYPICAN-3 POSITIVE HEPATOCELLULAR CARCINOMA
    Wang, B.
    Ngoh, E.
    Soh, M. K.
    Yeap, Y.
    Huang, H.
    Tan, H. C.
    Hu, Y.
    Wang, C. I.
    HUMAN GENE THERAPY, 2018, 29 (11) : A16 - A16
  • [49] IDENTIFYING THE FACTORS MODULATING THE EFFICACY OF CAR-T CELL THERAPY
    Dolnikov, A.
    Klamer, G.
    Shen, S.
    Chitranjan, A.
    Carol, H.
    Lock, R.
    O'Brien, T.
    CYTOTHERAPY, 2014, 16 (04) : S7 - S7
  • [50] Efficacy of B7H3-Targeted CAR T cell Therapy in a Novel Orthotopic Model of Osteosarcoma
    Talbot, Lindsay Jones
    Chabot, Ashley
    Funk, Amy
    Tillman, Heather
    Phuong Nguyen
    Wagner, Jessica
    Davidoff, Andrew
    Gottschalk, Stephen
    DeRenzo, Chris
    MOLECULAR THERAPY, 2021, 29 (04) : 315 - 315